| Literature DB >> 30910688 |
Mohammad Reza Etemadi1, Farid Azizi Jalilian2, Norlijah Othman3, Munn-Sann Lye4, Sara Ansari5, Putri Yubbu6, Zamberi Sekawi7.
Abstract
BACKGROUND: The role of respiratory viruses as the major cause of acute lower respiratory tract infections (ALRTIs) in children is becoming increasingly evident due to the use of sensitive molecular detection methods. The aim of this study was to use conventional and molecular detection methods to assess the epidemiology of respiratory viral infections in children less than five years of age that were hospitalized with ALRTIs.Entities:
Keywords: Hospitalized; Malaysia; Respiratory virus
Mesh:
Year: 2019 PMID: 30910688 PMCID: PMC7172173 DOI: 10.1016/j.jviromet.2019.03.013
Source DB: PubMed Journal: J Virol Methods ISSN: 0166-0934 Impact factor: 2.014
Single and Multiple Viral Infections by Viral Etiology (n = 165).
| Pathogens | Total | Single-infection | Double-infection | Triple-infection |
|---|---|---|---|---|
| 83 (50.3) | 49 (29.7) | 29(17.6) | 5(3.0) | |
| 54 (32.7) | 36 (21.8) | 14(8.5) | 4(2.4) | |
| 24 (14.5) | 3 (1.8) | 14 (8.5) | 7(4.2) | |
| 16 (9.6) | 8 (4.8) | 5(3.0) | 3(1.8) | |
| 15 (9.1) | 10 (6.1) | 3 (1.8) | 2(1.2) | |
| 8 (4.8) | 3 (1.8) | 2(1.2) | 3(1.8) | |
| 1 (0.6) | 0 | 0 | 1 (0.6) | |
| 3 (1.8) | 1 (0.6) | 1(0.6) | 1(0.6) | |
| 4 (2.4) | 2 (1.2) | 1(0.6) | 1(0.6) | |
| 6 (3.6) | 1 (0.6) | 3(1.8) | 2(1.2) | |
| 4 (2.4) | 0 | 3(1.6) | 1(0.6) | |
| 3 (1.8) | 2 (1.2) | 1(0.6) | 0 |
Numbers in parentheses, percentages.
Comparison of Conventional and Molecular Methods.
| Conventional | Molecular | ||
|---|---|---|---|
| Variables | Assaysa | Assay | |
| No. of detectable viruses | 9 | 14 | |
| No. of NPA tested | 165 | 165 | |
| No. (%) of positive NPA | 114 (69.1) | 158 (95.8) | <0.001d |
| No. of virus detected | 114 | 213 | <0.001e |
| No. of extra virus detected | 0 | 92 | |
| No. of samples with co-infections | 0 | 46 (27.9) | |
| RSV | 71 (43.0) | 83 (50.3) | <0.001 d |
| HMPV | 11 (6.7) | 16 (9.7) | 0.062 d |
| IFV-A | 3 (1.8) | 15 (9.1) | <0.001 d |
| IFV-B | 0 | 0 | – |
| PIV1 | 1 (0.6) | 1 (0.6) | – |
| PIV2 | 2 (1.2) | 3 (1.8) | – |
| PIV3 | 1 (0.6) | 4 (2.4) | – |
| HAdV | 5 (3.0) | 24 (14.5) | <0.001 d |
| – | |||
| PIV4 | NA | 0 | – |
| HRV | 27 (16.4) | 54 (32.7) | <0.001 d |
| HEV | NA | 3 (1.8) | – |
| HCOV OC43 | NA | 4 (2.4) | – |
| HCOV 229E | NA | 0 | – |
| HBoV | NA | 6 (3.6) | – |
aincluding DFA and SVC and conventional cell culture; NA: not available; b No of positive samples detected by conventional but not by molecular assay; cNo of positive samples detected by molecular but not immunological assay;d McNemar test; e Paired-samples t-test.
Fig. 1Monthly Distribution of RSV, HRV, HAdV, HMPV, and IFV-A Infections.